We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 26 april 2018

Oncogene - Table of Contents alert Volume 37 Issue 17

If you are unable to see the message below, click here to view.


Volume 37, Issue 17

In this issue
Brief Communications
Also new


PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma

Dima Ghannam-Shahbari, Eyal Jacob, Reli Rachel Kakun, Tanya Wasserman, Lina Korsensky et al.

Oncogene 2018 37 :2213 - 2224; January 30, 2018; 10.1038/s41388-017-0040-z

Abstract | Full Text

PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation

Yanlin Yu, Meng Dai, Andrew Lu, Ellen Yu & Glenn Merlino

Oncogene 2018 37 :2225 - 2236; February 02, 2018; 10.1038/s41388-017-0061-7

Abstract | Full Text

Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner

Femina Rauf, Fernanda Festa, Jin G. Park, Mitchell Magee, Seron Eaton et al.

Oncogene 2018 37 :2237 - 2250; February 05, 2018; 10.1038/s41388-017-0079-x

Abstract | Full Text

Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer

Özge Saatci, Simone Borgoni, Özge Akbulut, Selvi Durmus, Umar Raza et al.

Oncogene 2018 37 :2251 - 2269; February 02, 2018; 10.1038/s41388-017-0108-9

Abstract | Full Text

Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis

Jinah Park, Junil Kim, Bora Park, Kyung-Min Yang, Eun Jin Sun et al.

Oncogene 2018 37 :2270 - 2284; February 02, 2018; 10.1038/s41388-017-0102-2

Abstract | Full Text

Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis

Andras Ladanyi, Abir Mukherjee, Hilary A. Kenny, Alyssa Johnson, Anirban K. Mitra et al.

Oncogene 2018 37 :2285 - 2301; February 05, 2018; 10.1038/s41388-017-0093-z

Abstract | Full Text

Decitibine improve the efficiency of anti-PD-1 therapy via activating the response to IFN/PD-L1 signal of lung cancer cells

Qi Lai, Haiyong Wang, Angui Li, Yinhui Xu, Liang Tang et al.

Oncogene 2018 37 :2302 - 2312; February 09, 2018; 10.1038/s41388-018-0125-3

Abstract | Full Text

Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3

Na Li, Sarah Truong, Mannan Nouri, Jackson Moore, Nader Al Nakouzi et al.

Oncogene 2018 37 :2313 - 2325; February 12, 2018; 10.1038/s41388-017-0098-7

Abstract | Full Text

The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity

Andrew B. Fielding, Matthew Concannon, Sarah Darling, Emma V. Rusilowicz-Jones, Joseph J. Sacco et al.

Oncogene 2018 37 :2326 - 2342; February 12, 2018; 10.1038/s41388-017-0092-0

Abstract | Full Text

Brief Communications

BRCA1 function in the intra-S checkpoint is activated by acetylation via a pCAF/SIRT1 axis

Tyler J. Lahusen, Seung-Jin Kim, Kai Miao, Zebin Huang, Xiaoling Xu et al.

Oncogene 2018 37 :2343 - 2350; February 14, 2018; 10.1038/s41388-018-0127-1

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature